Results 11 to 20 of about 435,097 (243)

A prospective study of nutritional status in immunoglobulin light chain amyloidosis

open access: yesHaematologica, 2013
Weight loss is common in systemic immunoglobulin light chain amyloidosis but there are limited data on the impact of nutritional status on outcome.
Prayman T. Sattianayagam   +12 more
doaj   +1 more source

Analysis of Cardiac Amyloidosis Progression Using Model-Based Markers

open access: yesFrontiers in Physiology, 2020
Deposition of amyloid in the heart can lead to cardiac dilation and impair its pumping ability. This ultimately leads to heart failure with worsening symptoms of breathlessness and fatigue due to the progressive loss of elasticity of the myocardium ...
Wenguang Li   +11 more
doaj   +1 more source

Clinical profile and treatment outcome of older (>75 years) patients with systemic AL amyloidosis

open access: yesHaematologica, 2015
Systemic AL amyloidosis, a disease with improving outcomes using novel therapies, is increasingly recognized in the elderly but treatment and outcomes have not been systematically studied in this group of patients in whom comorbidities and frailty may ...
Sajitha Sachchithanantham   +10 more
doaj   +1 more source

Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry

open access: yesScientific Reports, 2021
Hereditary transthyretin-mediated (hATTR) amyloidosis is an underdiagnosed, progressively debilitating disease caused by mutations in the transthyretin (TTR) gene.
Margaret M. Parker   +21 more
doaj   +1 more source

C. elegans feed yolk to their young in a form of primitive lactation

open access: yesNature Communications, 2021
It is unclear why C. elegans continues to produce large quantities of yolk after reproduction. Here the authors show that post-reproductive C. elegans mothers vent yolk which supports their offspring’s growth, serving as a form of primitive lactation.
Carina C. Kern   +8 more
doaj   +1 more source

Proteomic Analysis for the Diagnosis of Fibrinogen Aα-chain Amyloidosis

open access: yesKidney International Reports, 2019
Introduction: Hereditary fibrinogen Aα-chain (AFib) amyloidosis is a relatively uncommon renal disease associated with a small number of pathogenic fibrinogen Aα (FibA) variants; wild-type FibA normally does not result in amyloid deposition.
Graham W. Taylor   +11 more
doaj   +1 more source

The importance of acute-phase proteins as markers in cancers

open access: yesStudia Medyczne, 2021
Acute-phase proteins (APPs) form a group of heterogeneous proteins whose synthesis takes place in the liver. This involves mediators such as cytokines and constitutes a response to acute inflammations, bacterial infections, tumours, and autoimmune ...
Paulina Zegarska   +2 more
doaj   +1 more source

Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein

open access: yesKidney International Reports, 2017
Fibrinogen A alpha chain amyloidosis is an autosomal dominant disease associated with mutations in the fibrinogen A alpha chain (FGA) gene, and it is the most common cause of hereditary renal amyloidosis in the UK.
Dorota Rowczenio   +18 more
doaj   +1 more source

Inhibition of the mechano-enzymatic amyloidogenesis of transthyretin: role of ligand affinity, binding cooperativity and occupancy of the inner channel

open access: yesScientific Reports, 2017
Dissociation of the native transthyretin (TTR) tetramer is widely accepted as the critical step in TTR amyloid fibrillogenesis. It is modelled by exposure of the protein to non-physiological low pH in vitro and is inhibited by small molecule compounds ...
Guglielmo Verona   +11 more
doaj   +1 more source

Acute phase proteins in sheep and goats – function, reference ranges and assessment methods: An overview [PDF]

open access: yesBulgarian Journal of Veterinary Medicine, 2018
Acute phase response (APR) is activated by disorders in systemic homeostasis. The main purpose of APR is to prevent further tissue damage by isolation and destruction of causative agent, removing the toxic products and providing conditions for tissue ...
P. Iliev, T. Mircheva-Georgieva
doaj   +1 more source

Home - About - Disclaimer - Privacy